
Leidos Hld (LDOS) Stock Forecast & Price Target
Leidos Hld (LDOS) Analyst Ratings
Bulls say
Leidos Holdings Inc. has demonstrated robust financial growth, particularly in its National Security and Defense Systems segments, with revenues rising 8% year-over-year to $2.02 billion and 11% to $582 million, respectively, outperforming market expectations. The company's Health & Civil segment has benefited from increased exam volumes, leading to improved margins and reinforcing its financial stability. Additionally, substantial growth in EBIT margins from 14.5% in 2023 to 22.5% in 2024, with anticipated continued strength at 24.3% in 1H25, indicates significant operational efficiency and profitability potential going forward.
Bears say
Leidos Holdings Inc. faces a challenging financial outlook, as its 2025 margin guidance indicates a meaningful decline in profitability during the second half of the year compared to the first half. The company's higher-margin managed health services segment may experience year-over-year declines due to increased competition and potential drops in medical exam volumes, which would add pressure on overall margins. Additionally, external risks, such as legal challenges regarding contract wins, potential impacts on defense spending from government stimulus measures, and the uncertainty surrounding government operations, further contribute to a negative sentiment around the company's stock performance.
This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.
Leidos Hld (LDOS) Analyst Forecast & Price Prediction
Start investing in Leidos Hld (LDOS)
Order type
Buy in
Order amount
Est. shares
0 shares